Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic avenues include gene silencing and modulation of repeat instability. However, there are major mechanistic gaps in our understanding of these processes, which prevent the rational design of an efficient treatment. To address this, we developed a novel system, ParB/ANCHOR-mediated Inducible Targeting (PInT), in which any protein can be recruited at will to a GFP reporter containing an expanded CAG/CTG repeat. Previous studies have implicated the histone deacetylase HDAC5 and the DNA methyltransferase DNMT1 as modulators of repeat instability via mechanisms that are not fully understood. Using PInT, we found no evidence that HDAC5 or DNMT1 modu...
The dynamic expansion of CAG.CTG repeats in otherwise unrelated genes is responsible for a growing n...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM...
Expanded CAG/CTG repeats underlie thirteen neurological disorders, including myotonic dystrophy (DM1...
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM...
Expanded CAG/CTG repeats underlie thirteen neurological disorders, including myotonic dystrophy (DM1...
The dynamic expansion of CAG.CTG repeats in otherwise unrelated genes is responsible for a growing n...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Expanded CAG/CTG repeat disorders affect over 1 in 2500 individuals worldwide. Potential therapeutic...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Epigenome editing is an attractive way to manipulate gene expression. However, editing efficiencies ...
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM...
Expanded CAG/CTG repeats underlie thirteen neurological disorders, including myotonic dystrophy (DM1...
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM...
Expanded CAG/CTG repeats underlie thirteen neurological disorders, including myotonic dystrophy (DM1...
The dynamic expansion of CAG.CTG repeats in otherwise unrelated genes is responsible for a growing n...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...
Despite substantial progress in understanding the mechanism by which expanded CTG/CAG trinucleotide ...